Biological characterization of human epithelial ovarian carcinoma cells in primary culture: The insulin-like growth factor system

Experimental Cell Research

Volumn 238, Issue 2, 1998, Pages 439-449

  Conover, C A ^a   Hartmann, L C ^a   Bradley, S ^a   Stalboerger, P ^a   Klee, G G ^a   Kalli, K R ^a   Jenkins, R B ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL GROWTH; GROWTH REGULATION; HUMAN; HUMAN CELL; OVARY CARCINOMA; PRIORITY JOURNAL;

EID: 0032004513     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1997.3861     Document Type: Article

References (62)

1. Wingo P. A., Tong T., Bolden S. Cancer statistics, 1995. CA Cancer J. Clin. 45:1995;8-30.
2. Henderson B. E., Ross R. K., Pike M. C. Toward the primary prevention of cancer. Science. 254:1991;1131-1138.
3. Devesa S. S., Blat W. J., Stone B. J., Miller B. A., Tarone R. E., Fraumeni J. F. Jr. Recent cancer trends in the United States. J. Natl. Cancer Inst. 87:1995;175-182.
4. Cliby W., Ritland S., Hartmann L., Dodson M., Halling K. C., Keeney G., Podratz K. C., Jenkins R. B. Human epithelial ovarian cancer allelotype. Cancer Res. 53:1993;2393-2398.
5. Dodson M. K., Hartmann L. C., Cliby W. A., DeLacey K. A., Keeney G. L., Ritland S. R., Su J. Q., Podratz K. C., Jenkins R. B. Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas. Cancer Res. 53:1993;4456-4460.
6. Jenkins R. B., Bartelt D. Jr., Stalboerger P., Persons D., Dahl R. J., Podratz K., Keeney G., Hartmann L. Cytogenetic studies of epithelial ovarian carcinoma. Cancer Genet. Cytogenet. 71:1993;76-86.
7. Shelling A. N., Cooke I. E., Ganesan T. S. The genetic analysis of ovarian cancer. Br. J. Cancer. 72:1995;521-527.
8. Daughaday W. H. The possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors. Endocrinology. 127:1990;1-4.
9. Cullen K. J., Yee D., Rosenfeld R. G. Insulinlike growth factors in human malignancy. Cancer Invest. 9:1991;443-454.
10. LeRoith D., Baserga R., Helman L., Roberts C. T. Jr. Insulin-like growth factors and cancer. Ann. Intern. Med. 122:1995;54-59.
11. Daughaday W. H., Rotwein P. Insulin-like growth factors I and II: Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocrinol. Rev. 10:1989;68-91.
12. Nissley P., Lopaczynski W. Insulin-like growth factor receptors. Growth Factors. 5:1991;29-43.
13. LeRoith D., Werner H., Beitner-Johnson D., Roberts C. T. Jr. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocrinol. Rev. 16:1995;143-163.
14. Baserga R. The insulin-like growth factor I receptor: A key to tumor growth? Cancer Res. 55:1995;249-252.
15. Shimasaki S., Ling N. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5, and -6). Prog. Growth Factor Res. 3:1991;243-266.
16. Oh Y., Nagalla S. R., Yamanaka Y., Kim H.-S., Wilson E., Rosenfeld R. G. Synthesis and characterization of insulin-like growth factor binding protein (IGFBP)-7. Recombinant human mac25 protein specifically binds IGF-I and -II. J. Biol. Chem. 271:1996;30322-30325.
17. Jones J. I., Clemmons D. R. Insulin-like growth factors and their binding proteins: Biological actions. Endocrinol. Rev. 16:1995;3-34.
18. Conover C. A. Glycosylation of insulin-like growth factor binding protein-3 (IGFBP-3) is not required for potentiation of IGF-I action: Evidence for processing of cell-bound IGFBP-3. Endocrinology. 129:1991;3259-3268.
19. 51. Proc. Natl. Acad. Sci. USA. 90:1993;10553-10557.
20. Oh Y., Muller H. L., Lamson G., Rosenfeld R. G. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells: Cell surface binding and growth inhibition. J. Biol. Chem. 268:1993;14964-14971.
21. Lee A. V., Yee D. Insulin-like growth factors and breast cancer. Biomed Pharmacother. 49:1995;415-421.
22. Kleinman D., Karas M., Roberts C. T. Jr., LeRoith D., Phillip M., Segev Y., Levy J., Sharoni Y. Modulation of insulin-like growth factor I (IGF-I) receptors and membrane-associated IGF-binding proteins in endometrial cancer cells by estradiol. Endocrinology. 136:1995;2531-2537.
23. Yee D., Morales F. R., Hamilton T. C., Von Hoff D. D. Expression of insulin-like growth factor I, its binding proteins, and its receptor in ovarian cancer. Cancer Res. 51:1991;5107-5112.
24. Resnicoff M., Ambrose D., Coppola D., Rubin R. Insulin-like growth factor-1 and its receptor mediate the autocrine proliferation of human ovarian carcinoma cell lines. Lab. Invest. 69:1993;756-760.
25. Hofmann J., Wegmann B., Hackenberg R., Kunzmann R., Schulz K.-D., Havemann K. Production of insulin-like growth factor binding proteins by human ovarian carcinoma cells. J. Cancer Res. Clin. Oncol. 120:1994;137-142.
26. Krywicki R. F., Figueroa J. A., Jackson J. G., Kozelsky T. W., Shimasaki S., Von Hoff D. D., Yee D. Regulation of insulin-like growth factor binding proteins in ovarian cancer cells by oestrogen. Eur. J. Cancer. 29A:1993;2015-2019.
27. Karasik A., Menczer J., Pariente C., Kanety H. Insulin-like growth factor-I (IGF-I) and IGF-binding protein-2 are increased in cyst fluids of epithelial ovarian cancer. J. Clin. Endocrinol. Metab. 78:1994;271-276.
28. Berns E. M. J. J., Klijn J. G. M., Henzen-Logmans S. C., Rodenburg C. J., Van Der Burg M. E. L., Foekens J. A. Receptors for hormones and growth factors and (onco)-gene amplification in human ovarian cancer. Int. J. Cancer. 52:1992;218-224.
29. Guidice L. C. The insulin-like growth factor system in normal and abnormal human ovarian follicle development. Am. J. Med. 98:1995;48S-54S.
30. Guidice L. C., Cataldo N. A., van Dessel H. J., Yap O. W., Chandrasakher Y. A. Growth factors in normal ovarian follicle development. Semin. Reprod. Endocrinol. 14:1996;179-196.
31. Zhou J., Bondy C. Anatomy of the human ovarian insulin-like growth factor system. Biol. Reprod. 48:1993;467-482.
32. Spurbeck J. L., Carlson R. O., Allen J. E., Dewald G. W. Culturing and robotic harvesting of bone marrow, lymph nodes, peripheral blood, fibroblasts, and solid tumors with in situ techniques. Cancer Genet. Cytogenet. 32:1988;59-66.
33. Conover C. A., Clarkson J. T., Bale L. K. Physiological concentrations of insulin induce cellular desensitization to the mitogenic effects of insulin-like growth factor I. Diabetes. 143:1994;1130-1137.
34. Conover C. A., Lee P. D. K., Riggs B. L., Powell D. R. Insulin-like growth factor-binding protein-1 expression in cultured human bone cells: regulation by insulin and glucocorticoid. Endocrinology. 137:1996;3295-3301.
35. Enjoh S. K.-i., Numata F., Fujiwara H., Marumoto Y., Higashihashi N., Sato Y., Perdue J. F., Fujita-Yamaguchi Y. The design, expression, and characterization of human insulin-like growth factor II (IGF-II) mutants specific for either the IGF-II/cation-independent mannose 6-phosphate receptor or IGF-I receptor. J. Biol. Chem. 266:1991;20626-20635.
36. 27. Endocrinology. 128:1991;1201-1203.
37. Hossenlopp P., Seurin D., Segovia-Quinson B., Hardouin S., Binoux M. Analysis of serum insulin-like growth factor binding proteins using Western blotting: Use of the method for titration of the binding proteins and competitive binding studies. Anal. Biochem. 154:1986;138-143.
38. Conover C. A., Kiefer M. C., Zapf J. Posttranslational regulation of insulin-like growth factor (IGF) binding protein-4 in normal and transformed human fibroblasts: IGF dependence and biological studies. J. Clin. Invest. 91:1993;1129-1137.
39. Conover C. A., Perry J. E., Tindall D. J. Endogenous cathepsin D-mediated hydrolysis of insulin-like growth factor binding proteins in cultured human prostatic carcinoma cells. J. Clin. Endocrinol. Metab. 80:1995;987-993.
40. DeLeon D. D., Terry C., Nissley S. P. Direct detection of insulin-like growth factor II (IGF-II) by chemiluminescence without interference by IGF binding proteins. Endocrinology. 134:1994;1960-1963.
41. DeLeon D. D., Asmerom Y. Quantification of insulin-like growth factor I (IGF-I) without interference by IGF binding proteins. Endocrinology. 138:1997;2199-2202.
42. Auersperg N., Siemens C. H., Myrdal S. E. Human ovarian surface epithelium in primary culture. In Vitro. 20:1984;743-755.
43. Siemens C. H., Auersperg N. Serial propagation of human ovarian surface epithelium in tissue culture. J. Cell. Physiol. 134:1988;347-356.
44. Auersperg N., Maines-Bandiera S. L., Dyck H. G., Kruk P. A. Characterization of cultured human ovarian surface epithelial cells: Phenotypic plasticity and premalignant changes. Lab. Invest. 71:1994;510-518.
45. Connell N. D., Rheinwald J. G. Regulation of the cytoskeleton in mesothelial cells: Reversible loss of keratin and increase in vimentin during rapid growth in culture. Cell. 34:1983;245-253.
46. LaRocca P. J., Rheinwald J. G. Coexpression of simple epithelial keratins and vimentin by human mesothelium and mesothelioma in vivo and in culture. Cancer Res. 44:1984;2991-2999.
47. Conover C. A. Regulation of insulin-like growth factor (IGF) binding protein synthesis by insulin and IGF-I in cultured bovine fibroblasts. Endocrinology. 26:1990;3139-3145.
48. Osborne C. K., Coronado E. B., Kitten L. J., Arteaga C. I., Fuqua S. A. W., Ramasharma K., Marshall M., Li C. H. Insulin-like growth factor-II (IGF-II): A potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor. Mol. Endocrinol. 3:1989;1701-1709.
49. Conover C. A. Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: Studies of underlying mechanism. Endocrinology. 130:1992;3191-3199.
50. Quinn K. A., Treston A. M., Unsworth E. J., Miller M.-J., Vos M., Grimley C., Battey J., Mulshine J. L., Cuttitta F. Insulin-like growth factor expression in human cancer cell lines. J. Biol. Chem. 271:1996;11477-11483.
51. Toretsky J. A., Helman L. J. Involvement of IGF-II in human cancer. J. Endocrinol. 149:1996;367-372.
52. Yun K., Fukumoto M., Hinno Y. Monoallelic expression of the insulin-like growth factor-2 gene in ovarian cancer. Am. J. Pathol. 148:1996;1081-1087.
53. Christofori G., Naik P., Hanahan D. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature. 369:1994;414-418.
54. Huynh H., Alpert L., Pollak M. Pregnancy-dependent growth of mammary tumors is associated with overexpression of insulin-like growth factor II. Cancer Res. 56:1996;3651-3654.
55. Nissley P., Kiess W., Sklar M. M. The insulin-like growth factor-II/mannose 6-phosphate receptor. Insulin-Like Growth Factors: Molecular and Cellular Aspects. 1991;CRC Press, Boca Raton. p. 111-150.
56. Chen J.-C., Shao Z.-M., Sheikh M. S., Hussain A., LeRoith D., Roberts C. T. Jr., Fontana J. A. Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line. J. Cell. Physiol. 158:1994;69-78.
57. Kanety H., Kattan M., Goldberg I., Kopolovic J., Ravia J., Menczer J., Karasik A. Increased insulin-like growth factor binding protein-2 (IGFBP-2) gene expression and protein production lead to high IGFBP-2 content in malignant ovarian cyst fluid. Br. J. Cancer. 73:1996;1069-1073.
58. Bast R. C. Jr., Klug T. L., St. John E., Jenison E., Niloff J. M., Lazarus H., Berkowitz R. S., Leavitt T., Griffiths C. T., Parker L., Zurawski V. R. Jr., Knapp R. C. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N. Engl. J. Med. 309:1983;883-887.
59. Wimalasena J., Meehan D., Cavallo C. Human epithelial ovarian cancer cell steroid secretion and its control by gonadotropins. Gynecol. Oncol. 41:1991;56-63.
60. Marth C., Zeimet A. G., Widschwendter M., Ludescher C., Kærn J., Tropé C., Gastl G., Daxenbichler G., Dapunt O. Paclitaxel- and docetaxel-dependent activation of CA-125 expression in human ovarian carcinoma cells. Cancer Res. 57:1997;3818-3822.
61. Mutch D. G., Williams S. Biology of epithelial ovarian cancer. Clin. Obstet. Gynecol. 37:1994;406-422.
62. Schildkraut J. M., Bastos E., Berchuck A. Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer. J. Natl. Cancer Inst. 89:1997;932-938.